Publication date: 19 Apr 2019
Rachel Clemens, Eva Wu and Imran Babar represented the Rare Genomics Institute at April’s World Orphan Drug Congress in Maryland. The three day congress brought together over 1,200 participants from government, commercial and patient advocacy groups interested in orphan drug development and rare disease research.